Is MannKind Corp (MNKD) undervalued? · rev $285.5M
MannKind Corp (MNKD) is a biotechnology company listed on US.
This page asks whether MannKind Corp (MNKD) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported MNKD revenue for 2024-12-31 was $285.5M. Net income was $27.6M. Revenue was up 43.5% from 2023-12-31 to 2024-12-31. MNKD currently screens at market cap $1.28B.
MNKD currently screens at market cap $1.28B. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new MNKD 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare MNKD to the stock page model before you treat a low multiple as a gift.
Not investment advice.